HCN News Team – Page 66 – Highly Capitalized

Thursday, March 26, 2026 We Follow The Money.

About HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Indigenous Tribes Expand Presence in U.S. Cannabis and Hemp Sectors

HCN News Team2025-05-26T06:59:46-08:00May 26th, 2025|Insights|

LOS ANGELES- A recent analysis by the Indigenous Cannabis Industry ...

Colorado Court Dismisses Mammoth Farms’ Lawsuit Against Marijuana Enforcement Division

HCN News Team2025-05-26T06:55:21-08:00May 26th, 2025|Justice|

LOS ANGELES- A Denver District Court has dismissed a lawsuit ...

Thailand Moves to Restrict Cannabis Use to Medical Purposes Within 40 Days

HCN News Team2025-05-23T06:05:53-08:00May 23rd, 2025|World|

LOS ANGELES- Thailand's Public Health Minister, Somsak Thepsutin, has announced ...

The Cannabist Company Receives Court Approval for Corporate Restructuring Plan

HCN News Team2025-05-23T05:06:28-08:00May 23rd, 2025|Insights|

LOS ANGELES- The Cannabist Company Holdings Inc. a U.S.-based cannabis ...

Canada’s Legal Cannabis Market Forecasted to Reach $5.79 Billion by 2030

HCN News Team2025-05-23T04:57:39-08:00May 23rd, 2025|Capital|

LOS ANGELES- Canada's legal cannabis industry is projected to expand ...

Humboldt Family Farms: Terroir and Cannabis

HCN News Team2025-05-23T05:08:25-08:00May 23rd, 2025|Brands, Insights|

The concept of terroir, traditionally rooted in French viticulture, refers ...

Texas Republicans Approve Total Ban on Hemp-Derived THC Products

HCN News Team2025-05-22T14:47:00-08:00May 22nd, 2025|Business|

DALLAS-In a sweeping move that could reshape Texas' booming hemp ...

Analysis: Germany Legalized Cannabis. Now the Real Work Begins.

HCN News Team2025-05-22T14:05:52-08:00May 22nd, 2025|Business, World|

BERLIN-On April 1, 2024, Germany made history by legalizing adult-use ...

Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study

HCN News Team2025-05-22T07:25:44-08:00May 22nd, 2025|Psychedelics|

LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced ...

Tilray Medical Introduces Good Supply Cannabis Brand to German Market

HCN News Team2025-05-22T07:24:12-08:00May 22nd, 2025|World|

LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc ...

Previous 656667 Next

DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405

© Copyright | Highly Capitalized | All Rights Reserved | Website by Vadimages.